J B Hunt Transport Services Inc vs McKesson Corporation — how do they compare? J B Hunt Transport Services Inc trades at $294.9 (market cap $27.36B), while McKesson Corporation trades at $832.45 (market cap $97.35B). The key difference: McKesson Corporation is far larger — about 3.6× J B Hunt Transport Services Inc's market cap, and J B Hunt Transport Services Inc pays the higher dividend (0.62%). Which is the better fit depends on your goals.
| JBHT | MCK | |
|---|---|---|
Market Cap | $27.36B | $97.35B |
Sector | Industrials | Health |
52-Week High | $298.41 | $995.69 |
52-Week Low | $130.65 | $659.01 |
Enterprise Value | $28.50B | $101.98B |
Dividend Yield | 0.62% | 0.39% |
Signals from Pluang's Aura AI — not financial advice
J.B. Hunt Transport Services (JBHT) trades at $293.26, up 0.63% today, near its 52-week high. The stock shows a bullish technical trend with strong moving averages and has beaten earnings estimates for three consecutive quarters. Recent Q2 2026 results featured EPS of $1.91 versus $1.71 expected, driven by intermodal growth and cost discipline. Revenue for 2025 was $12.00B with a net income margin of 4.98%. Analysts maintain a Buy consensus with a $299.82 price target, citing freight market recovery and margin expansion.
The outlook for JBHT is positive, supported by structural industry shifts toward rail and efficient network operations. Investment opportunities include continued earnings momentum and potential price appreciation toward the $345 high target. Risks involve premium valuation (P/E 41.45), economic sensitivity, and competitive pressures. The stock's current level demands careful valuation assessment despite favorable fundamentals and analyst optimism.
McKesson (MCK) trades at $828.84, down 1.49% on the day, with a bullish technical outlook supported by moving averages and key support at $826. The company shows strong revenue growth, reaching $359.05B in 2025, and has beaten EPS estimates for three consecutive quarters. Analyst sentiment is overwhelmingly positive with 24 buy ratings and a consensus price target of $932.83, indicating 12.5% upside potential.
The outlook for MCK remains favorable due to consistent earnings beats, robust cash flow generation, and leadership in healthcare distribution. Risks include thin profit margins (1.18% net margin) and high liabilities relative to equity. Investors should focus on execution in specialty pharma and oncology services as key growth drivers amid competitive and regulatory pressures.
Trailing returns across standard periods
Latest headlines on both assets
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).
Read more on JBHT →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →